Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Two types of recessive hereditary spastic paraplegia in Roma patients in compound heterozygous state; no ethnically prevalent variant found

AU. Meszarosova, P. Seeman, J. Jencik, J. Drabova, R. Cibochova, J. Stellmachova, D. Safka Brozkova

. 2020 ; 721 (-) : 134800. [pub] 20200130

Language English Country Ireland

Document type Journal Article, Research Support, Non-U.S. Gov't

Grant support
NV15-31899A MZ0 CEP Register

Hereditary spastic paraplegia (HSP or SPG) is a group of rare upper motor neuron diseases. As some ethnically-specific, disease-causing homozygous variants were described in the Czech Roma population, we hypotesised that some prevalent HSP-causing variant could exist in this population. Eight Czech Roma patients were found in a large group of Czech patients with suspected HSP and were tested using gene panel massively parallel sequencing (MPS). Two of the eight were diagnosed with SPG11 and SPG77, respectively. The SPG77 patient manifests a pure HSP phenotype, which is unusual for this SPG type. Both patients are compound heterozygotes for two different variants in the SPG11 (c.1603-1G>A and del ex. 16-18) and FARS2 (c.1082C>T and del ex.1-2) genes respectively; the three variants are novel. In order to find a potential ethnically-specific, disease-causing variant for HSP, we tested the heterozygote frequency of these variants among 130 anonymised DNA samples of Czech Roma individuals without clinical signs of HSP (HPS-negative). A novel deletion of ex.16-18 in the SPG11 gene was found in a heterozygous state in one individual in the HSP-negative group. Haplotype analysis showed that this individual and the patient with SPG11 shared the same haplotype. This supports the assumption that the identified SPG11 deletion could be a founder mutation in the Czech Roma population. In some Roma patients the disease may also be caused by two different biallelic pathogenic mutations.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21020683
003      
CZ-PrNML
005      
20250109144603.0
007      
ta
008      
210728e20200130ie f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.neulet.2020.134800 $2 doi
035    __
$a (PubMed)32007496
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ie
100    1_
$a Meszarosova, Anna Uhrova $u DNA Laboratory, Department of Paediatric Neurology, 2nd Faculty of Medicine Charles University and University Hospital Motol, Prague, Czech Republic. Electronic address: anna.meszarosova@lfmotol.cuni.cz
245    10
$a Two types of recessive hereditary spastic paraplegia in Roma patients in compound heterozygous state; no ethnically prevalent variant found / $c AU. Meszarosova, P. Seeman, J. Jencik, J. Drabova, R. Cibochova, J. Stellmachova, D. Safka Brozkova
520    9_
$a Hereditary spastic paraplegia (HSP or SPG) is a group of rare upper motor neuron diseases. As some ethnically-specific, disease-causing homozygous variants were described in the Czech Roma population, we hypotesised that some prevalent HSP-causing variant could exist in this population. Eight Czech Roma patients were found in a large group of Czech patients with suspected HSP and were tested using gene panel massively parallel sequencing (MPS). Two of the eight were diagnosed with SPG11 and SPG77, respectively. The SPG77 patient manifests a pure HSP phenotype, which is unusual for this SPG type. Both patients are compound heterozygotes for two different variants in the SPG11 (c.1603-1G>A and del ex. 16-18) and FARS2 (c.1082C>T and del ex.1-2) genes respectively; the three variants are novel. In order to find a potential ethnically-specific, disease-causing variant for HSP, we tested the heterozygote frequency of these variants among 130 anonymised DNA samples of Czech Roma individuals without clinical signs of HSP (HPS-negative). A novel deletion of ex.16-18 in the SPG11 gene was found in a heterozygous state in one individual in the HSP-negative group. Haplotype analysis showed that this individual and the patient with SPG11 shared the same haplotype. This supports the assumption that the identified SPG11 deletion could be a founder mutation in the Czech Roma population. In some Roma patients the disease may also be caused by two different biallelic pathogenic mutations.
650    _2
$a mladiství $7 D000293
650    _2
$a dospělí $7 D000328
650    _2
$a dítě $7 D002648
650    _2
$a předškolní dítě $7 D002675
650    _2
$a etnicita $x genetika $7 D005006
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a genetická variace $x genetika $7 D014644
650    12
$a heterozygot $7 D006579
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a mitochondriální proteiny $x genetika $7 D024101
650    _2
$a rodokmen $7 D010375
650    _2
$a fenylalanin-tRNA-ligasa $x genetika $7 D010652
650    _2
$a proteiny $x genetika $7 D011506
650    _2
$a Romové $x etnologie $x genetika $7 D006178
650    _2
$a spastická paraplegie dědičná $x diagnóza $x etnologie $x genetika $7 D015419
650    _2
$a mladý dospělý $7 D055815
651    _2
$a Česká republika $x etnologie $7 D018153
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Seeman, Pavel $u DNA Laboratory, Department of Paediatric Neurology, 2nd Faculty of Medicine Charles University and University Hospital Motol, Prague, Czech Republic
700    1_
$a Jencik, Jan $u DNA Laboratory, Department of Paediatric Neurology, 2nd Faculty of Medicine Charles University and University Hospital Motol, Prague, Czech Republic
700    1_
$a Drabova, Jana $u Department of Biology and Medical Genetics, 2nd Faculty of Medicine Charles University and University Hospital Motol, Prague, Czech Republic
700    1_
$a Cibochová, Renata $u Department of Paediatric Neurology, 2nd Faculty of Medicine Charles University and University Hospital Motol, Prague, Czech Republic $7 xx0079953
700    1_
$a Stellmachova, Julia $u Department of Medical Genetics, Palacky University Hospital, Olomouc, Czech Republic
700    1_
$a Safka Brozkova, Dana $u DNA Laboratory, Department of Paediatric Neurology, 2nd Faculty of Medicine Charles University and University Hospital Motol, Prague, Czech Republic
773    0_
$w MED00003507 $t Neuroscience letters $x 1872-7972 $g Roč. 721 (20200130), s. 134800
856    41
$u https://pubmed.ncbi.nlm.nih.gov/32007496 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20210728 $b ABA008
991    __
$a 20250109144557 $b ABA008
999    __
$a ok $b bmc $g 1691290 $s 1141129
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 721 $c - $d 134800 $e 20200130 $i 1872-7972 $m Neuroscience letters $n Neurosci. lett. $x MED00003507
GRA    __
$a NV15-31899A $p MZ0
LZP    __
$a Pubmed-20210728

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...